Location History:
- Tonbridge, GB (1987)
- Beckenham, GB (1992 - 1998)
Company Filing History:
Years Active: 1987-1998
Title: Alistair A Miller: Innovator in CNS Compounds
Introduction
Alistair A Miller is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target central nervous system (CNS) disorders. With a total of 7 patents to his name, Miller's work has the potential to impact the treatment of various neurological conditions.
Latest Patents
Miller's latest patents include innovative compounds such as 2-(n-alkylpiperazino or morpholino)-4-amino-5-aryl-pyrimidines. This class of substituted phenylpyrimidine compounds has been identified as potent inhibitors of the excitatory amino acid, glutamate. These compounds are particularly useful in the treatment or prevention of a range of CNS disorders, including cerebral ischaemic damage and epilepsy. Another significant patent involves pharmacologically active CNS compounds, which also serve as inhibitors of glutamate, further emphasizing their therapeutic potential.
Career Highlights
Throughout his career, Alistair A Miller has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Burroughs Wellcome Co. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Miller has collaborated with notable professionals in his field, including Malcolm Stuart Nobbs and Richard M Hyde. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Alistair A Miller's contributions to the field of pharmacology, particularly in the development of CNS compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of neurological disorders.